Maximum Dose of Venlafaxine Extended-Release
The maximum recommended dose of venlafaxine extended-release for adults is 225 mg/day in outpatient settings, though doses up to 375 mg/day may be used in certain patients, particularly those with more severe depression. 1
Dosing Framework
Standard Maximum Dosing
- Outpatients with moderate depression: 225 mg/day is the ceiling dose, as there was no evidence of additional benefit beyond this dose in clinical trials 1
- More severely depressed patients: May respond to higher doses up to a maximum of 375 mg/day 1
- In inpatient studies, severely depressed patients responded to a mean dose of approximately 350 mg/day 1
Dose Escalation Strategy
When increasing the dose:
- Increments should be up to 75 mg/day
- Allow at least 4 days between dose increases 1
- Start at 75 mg/day and titrate based on tolerability and clinical response 1
Special Populations Requiring Dose Reduction
Hepatic Impairment
- Reduce total daily dose by 50% in patients with mild to moderate hepatic impairment 1
- Individual variability is substantial; some patients may require greater than 50% reduction 1
Renal Impairment
- Reduce total daily dose by 25% for GFR 10-70 mL/min 1
- Reduce total daily dose by 50% for patients on hemodialysis 1
Elderly Patients
- No specific dose adjustment required based on age alone
- Exercise caution when increasing doses in this population 1
Clinical Context from Research
The dose-response relationship for venlafaxine shows efficacy increasing up to approximately 75-150 mg, followed by more modest gains at higher doses 2. Studies examining high-dose venlafaxine (up to 600 mg/day) found it tolerable, though with increased frequency and severity of side-effects at doses above 375 mg/day 3. However, these ultra-high doses exceed FDA-approved maximums and should not be used in routine practice.
Important Safety Consideration
Monitor blood pressure at doses above 300 mg/day, as dose-dependent blood pressure elevation occurs in approximately 13% of patients receiving more than 300 mg/day versus 2% on placebo 4. At doses of 201-300 mg/day, this occurs in 7% of patients 4.
The practical ceiling for most patients remains 225 mg/day, with the 375 mg/day maximum reserved for treatment-resistant or severely depressed patients who have not responded adequately to lower doses and can tolerate the medication 1.